We are live on ! Find out more
VXRT

Vaxart

Delisted

VXRT was delisted on the 7th of July, 2025.

88 hedge funds and large institutions have $173M invested in Vaxart in 2020 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 15 increasing their positions, 9 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 8

222% more capital invested

Capital invested by funds: $53.9M → $173M (+$119M)

120% more funds holding

Funds holding: 4088 (+48)

67% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 9

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

16.59% less ownership

Funds ownership: 43%26.42% (-17%)

Holders
88
Holders Change
+48
Holders Change %
+120%
% of All Funds
1.8%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
56
Increased
15
Reduced
9
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$29.8M +$8.18M +2,849,025 +550%
Citadel Advisors
2
Citadel Advisors
Florida
$27.4M +$8.9M +3,096,964 New
VA
3
VR Adviser
New York
$24.5M +$7.94M +2,765,000 New
BBA
4
Baker Bros. Advisors
New York
$14.5M +$4.71M +1,639,121 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$9.3M +$1.17M +406,286 +63%
Millennium Management
6
Millennium Management
New York
$7.88M +$2.47M +859,603 +2,847%
State Street
7
State Street
Massachusetts
$6.91M +$2.24M +780,422 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$5.76M +$899K +312,960 +92%
Renaissance Technologies
9
Renaissance Technologies
New York
$5.46M -$4.47M -1,557,400 -72%
Northern Trust
10
Northern Trust
Illinois
$5.34M +$1.49M +518,183 +606%
Goldman Sachs
11
Goldman Sachs
New York
$3.53M +$1.15M +398,848 New
QI
12
QS Investors
New York
$3.34M
UBS Group
13
UBS Group
Switzerland
$2.68M +$832K +289,761 +2,247%
Prudential Financial
14
Prudential Financial
New Jersey
$2.57M +$836K +290,907 New
Jane Street
15
Jane Street
New York
$1.81M +$589K +205,177 New
Bank Julius Baer & Co
16
Bank Julius Baer & Co
Switzerland
$1.78M -$119K -41,260 -17%
HSA
17
Hussman Strategic Advisors
Maryland
$1.77M -$862K -300,000 -60%
AG
18
Artal Group
Luxembourg
$1.77M +$575K +200,000 New
N
19
Nuveen
North Carolina
$1.75M +$567K +197,318 New
AC
20
Armistice Capital
New York
$1.29M -$72M -25,054,477 -99%
Barclays
21
Barclays
United Kingdom
$1.22M +$394K +137,203 New
Bank of New York Mellon
22
Bank of New York Mellon
New York
$1.1M +$239K +83,096 +199%
Charles Schwab
23
Charles Schwab
California
$1.06M +$345K +120,182 New
Balyasny Asset Management
24
Balyasny Asset Management
Illinois
$942K +$306K +106,425 New
AllianceBernstein
25
AllianceBernstein
Tennessee
$770K +$250K +87,000 New

VXRT Hedge Fund Activity: Q2 2020 in Review

88 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q2 2020, worth a combined $173M — up 222% from $53.9M a quarter earlier.

Buyers outnumbered sellers: 56 funds opened new VXRT positions and 8 closed out — a net gain of 48 holders — while 15 added to existing stakes and 9 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $8.9M. The largest seller was Armistice Capital, cutting an estimated $72M.

  • 88 institutional investors held Vaxart (VXRT) as of Q2 2020, up from 40 in Q1 2020.
  • Funds reported $173M of Vaxart stock for Q2 2020, up 222% quarter-over-quarter.
  • 56 funds opened new Vaxart positions in Q2 2020 and 8 closed out, a net change of +48 holders.
  • The largest Vaxart buyer in Q2 2020 was Citadel Advisors, an estimated $8.9M added.
  • The largest Vaxart seller in Q2 2020 was Armistice Capital, an estimated $72M sold.

Based on aggregated 13F filings for Q2 2020.